Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: golfer72 who wrote (1325421)	10/20/2021 3:42:20 PM
From: J_F_Shepard	2 Recommendations Recommended By Brumar89 pocotrader Read Replies (2) \| Respond to of 1571789

Ivermectin has been used succesfully especially in India. Its not a panacea but part of an overall strategy to treat Covid. Its suppression is criminal. Wrong again....!!! Douche..... https://www.precisionvaccinations.com/2021/09/25/india-de-approves-hydroxycholoquine-and-ivermectin India De-Approves Hydroxycholoquine and Ivermectin September 25, 2021 • 9:01 am CDT The Indian Council of Medical Research ( ICMR) confirmed on September 24, 2021, it has removed usage of Ivermectin and Hydroxycholoquine from its approved COVID-19 treatment guidelines. Experts at the ICMR did not find enough evidence for Ivermectin and Hydroxycholoquine as potential therapeutics targeted against COVID-19, stated Samiran Panda, head of epidemiology and infectious diseases at ICMR. ET reported, "A lot of discussions took place, and the experts finally came to the conclusion that there is not enough evidence that proves the effectiveness of both the drugs. Hence, we decided to drop them from the clinical guidelines for the management of Covid-19 patients," Dr. Samiran Panda stated. Plaquenil ( Hydroxychloroquine) is U.S. FDA-approved to treat certain types of malaria and autoimmune conditions such as chronic discoid lupus erythematosus, systemic lupus erythematosus in adults, and rheumatoid arthritis. And, Ivermectin tablets are approved by the U.S. FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms. — Karen McClorey Hackett